Veeraj Group

Directions Website Contact the business

Veeraj Group Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Veeraj Group, Chemical company, Ahmedabad.

What if the next decade's competitive advantage isn't built on cost — but on the courage to build capacity when others h...
11/11/2026

What if the next decade's competitive advantage isn't built on cost — but on the courage to build capacity when others hesitate?

India's specialty chemicals sector is at an inflection point. Global market share: 4% today. Projected: 12% by 2040. The sector is expected to hit $60 billion by 2026, riding a $900+ billion global market by 2028.

The catalyst? China+1 diversification. Global buyers are actively de-risking supply chains, and India's capabilities in oleochemicals, specialty resins, pharma intermediates, and advanced coatings are capturing that momentum.

But this isn't just about opportunity — it's about ex*****on infrastructure. The companies that will win aren't just those with chemistry expertise. They're the ones building end-to-end ecosystems: reliable sourcing, compliant manufacturing, logistics resilience, and export facilitation that meets global standards.

At Veeraj Group, we've spent nearly four decades building exactly that — from industrial chemical distribution to turnkey infrastructure construction. We've seen market shifts before. This one is different. It's not a cycle. It's a structural realignment.

The question for industrial leaders today: Are you positioned to capture India's specialty chemicals moment — or watching it from the sidelines?

Building the Future, Rooted in Legacy.

What if 90% of an industry believed in a transformation, but only 52% knew how to execute it?That's the reality facing t...
11/11/2026

What if 90% of an industry believed in a transformation, but only 52% knew how to execute it?

That's the reality facing the global chemical sector today.

Europe's chemical industry reports near-universal commitment to circular economy principles. Yet a 30-point ex*****on gap separates ambition from action. Meanwhile, India's oleochemicals market is surging at 7.09% CAGR, racing toward 4.07 million tonnes by 2034—but with a 538,000-tonne net import dependency and barely 3% certified sustainable supply.

The convergence is unmistakable. Global demand for bio-based, circular feedstocks is accelerating toward USD 45.3 billion by 2033. The infrastructure to deliver it at scale? Still under construction.

This is where legacy meets opportunity.

For nearly four decades, we've built our foundation on understanding that industrial transformation isn't about declaring intent—it's about engineering ex*****on. From specialty resins to oleochemical distribution, from turnkey infrastructure to export facilitation, the question has always been the same: can you deliver what the market will demand three years from now?

The circular economy isn't a trend. It's a supply chain realignment that will redefine competitive advantage in chemicals, pharmaceuticals, and industrial manufacturing.

The companies that close the ex*****on gap today will own the infrastructure tomorrow.

Are you building for the transition, or waiting for it to arrive?

creativeRef: creatives/images/image_1794162932946_0.pngWhen tariffs rewrite the rulebook, who wins?Not the companies wit...
08/11/2026

creativeRef: creatives/images/image_1794162932946_0.png

When tariffs rewrite the rulebook, who wins?

Not the companies with the lowest cost. The ones with the deepest regulatory expertise.

The specialty chemicals industry is in the middle of a supply chain realignment that will define the next decade. U.S. tariff policies targeting Chinese imports are forcing manufacturers to reformulate products, switch suppliers, and rethink their entire sourcing strategy—especially in personal care, pharma APIs, agrochemicals, and CASE applications.

Here's what most miss: tariff impact varies wildly by product code. A 2% shift in formulation can mean the difference between a 25% duty and zero. That granularity creates asymmetric advantage for distributors and export facilitators who understand both chemistry and compliance.

India is moving fast. Tata Chemicals committed ₹910 crore to expand capacity. Deepak Nitrite announced ₹3,720 crore in new projects. Godrej Industries allocated ₹750 crore for oleochemicals—a market projected to grow from $33.6 billion to $56.9 billion by 2035.

The companies that thrive in this environment won't be the ones waiting for clarity. They'll be the ones turning regulatory complexity into competitive moats—advising clients on reformulation pathways, navigating HS code nuances, and building resilient multi-geography supply networks.

At Veeraj Group, we've spent nearly four decades learning that industrial leadership isn't about reacting to change. It's about architecting around it.

What if the biggest risk in your supply chain isn't a single point of failure — but the entire network itself?Since 2022...
08/11/2026

What if the biggest risk in your supply chain isn't a single point of failure — but the entire network itself?

Since 2022, over 120 chemical plants have closed globally. 65% of them in Europe. The era of single, optimized global supply chains is ending. What's replacing it isn't just diversification — it's a fundamental shift to portfolios of regional production options.

Deloitte's 2027 Chemical Industry Outlook reveals the new playbook: companies are no longer choosing between global efficiency and local resilience. They're building both. Regional hubs. Customer-proximate infrastructure. Localized storage networks that can pivot when geopolitics disrupts trade corridors overnight.

This isn't about abandoning globalization. It's about architecting optionality into every molecule that moves.

For nearly four decades, Veeraj Group has understood what others are now discovering: infrastructure isn't overhead — it's strategic advantage. Our chemical distribution, turnkey construction capabilities, and global export facilitation were built on a simple principle: when supply chains become strategy, proximity and adaptability win.

The question isn't whether your supply chain will face disruption. It's whether your infrastructure can respond when it does.

Are you building for resilience, or still optimizing for a world that no longer exists?

What if the next decade's competitive advantage in chemicals isn't built in boardrooms—but in ports, pipelines, and indu...
07/11/2026

What if the next decade's competitive advantage in chemicals isn't built in boardrooms—but in ports, pipelines, and industrial corridors?

India is betting $1 trillion on that answer.

By 2040, the country aims to transform its chemical sector from a $178 billion trade-deficit industry into a zero-deficit, globally integrated powerhouse. The strategy? Eight dedicated port-based chemical clusters, each designed to collapse the distance between raw material import, processing, and export.

This isn't incremental improvement. It's infrastructure-led industrial repositioning.

• Global value chain share: 3.5% → 12%
• Trade deficit: $31 billion → zero by 2030
• New framework: resilience over efficiency

The EU-India FTA—concluded January 2026—adds fuel. Zero tariffs on 97.5% of Indian chemical exports. But the real unlock isn't tariff relief. It's compliance infrastructure. REACH-ready facilities. GMP-certified plants. Traceability from molecule to market.

For nearly four decades, Veeraj Group has built at the intersection of chemicals and infrastructure—specialty resins, oleochemicals, turnkey industrial construction. We've seen markets shift from cost arbitrage to supply chain sovereignty.

The question for CTOs and industrial leaders today: Are you building for the last cycle's efficiency—or the next cycle's resilience?

India stopped waiting for permission. The infrastructure is rising.

What happens when supply chains stop being a cost center and become your competitive moat?For nearly four decades, the c...
06/11/2026

What happens when supply chains stop being a cost center and become your competitive moat?

For nearly four decades, the chemical industry optimized for efficiency. Lean inventories. Single-source suppliers. Just-in-time everything. Then geopolitics rewrote the playbook overnight.

Today's industrial leaders aren't asking "how do we cut costs?" They're asking "how do we build optionality?"

Deloitte's 2027 Chemical Industry Outlook confirms what we've been building toward: the future belongs to companies that can operate dual models—commodity volume AND specialty value—without compromise. It's not about choosing between scale and agility. It's about engineering both into your foundation.

India's specialty chemicals sector is on track to capture 10%+ global market share, up from 4% today. ₹16,500 crore in new capex. R&D infrastructure that didn't exist five years ago. Government incentives designed for exactly this inflection point.

But infrastructure moves faster than strategy in most boardrooms.

At Veeraj Group, we've spent 38 years building the industrial backbone that makes optionality possible—chemical distribution networks that don't break under volatility, turnkey infrastructure that adapts to portfolio shifts, export facilitation that turns regulatory complexity into competitive advantage.

The companies that will lead the next decade aren't the ones with the lowest costs. They're the ones who built resilience before they needed it.

Are you ready for what supply chain optionality actually demands?

₹1.8 lakh crore says India stopped waiting.While global supply chains were still recalibrating, India announced the larg...
04/11/2026

₹1.8 lakh crore says India stopped waiting.

While global supply chains were still recalibrating, India announced the largest industrial infrastructure buildout in a generation. Four NICDC mega-projects. Three BHAVYA chemical parks. Plug-and-play CETP, TSDF, and logistics infrastructure ready to deploy.

This isn't aspiration. It's ex*****on at scale.

Tumakuru. Krishnapatnam. Nangal Chaudhary. Dadri. These aren't just locations—they're the new coordinates of India's chemical manufacturing future. 2.96 lakh jobs. Integrated utilities. Pre-approved environmental compliance. The infrastructure that took decades to build elsewhere is being delivered in years.

BCG projects India's chemical market will double from $150 billion to $300 billion by 2030. The question isn't whether the demand exists. It's whether your operations are positioned where the infrastructure is being built.

The companies moving now aren't chasing incentives. They're securing operational advantage in markets where speed, compliance, and integration determine who scales and who stalls.

Legacy isn't what you inherit. It's what you build when the infrastructure aligns with the opportunity.

The future isn't waiting. Neither should you.

When Trade Policy Moves Faster Than MarketsOn July 23, 2026, the U.S. Commerce Department imposed countervailing duties ...
04/11/2026

When Trade Policy Moves Faster Than Markets

On July 23, 2026, the U.S. Commerce Department imposed countervailing duties on oleochemical imports — 16.47% on Indonesia, 4.2% on Malaysia. Overnight, the global oleochemicals supply chain shifted.

But here's what most missed: this wasn't just about tariffs.

The $10 billion oleochemicals market is caught in a three-way collision — trade enforcement, biofuel feedstock competition, and geopolitical supply chain disruption. Palm oil prices are climbing. Biodiesel mandates are tightening feedstock availability. And industrial buyers are scrambling to reconfigure decades-old sourcing strategies.

For chemical manufacturers, pharma companies, and industrial enterprises, this is a defining moment. The companies that treat this as a compliance issue will lose margin. The ones that see it as a strategic inflection point will gain optionality.

At Veeraj Group, we've spent nearly four decades navigating industrial transformation — from specialty resins to oleochemicals distribution to turnkey infrastructure. We know that resilience isn't built in the crisis. It's built in the decisions you make before the next disruption hits.

The question isn't whether your supply chain can absorb a 16% duty increase.

It's whether your sourcing strategy can survive the next policy shift — and the one after that.

Building the Future, Rooted in Legacy.

What if the next supply chain crisis could be prevented by infrastructure you build today?India just committed ₹3,030 cr...
03/11/2026

What if the next supply chain crisis could be prevented by infrastructure you build today?

India just committed ₹3,030 crore to three integrated chemical parks under the Bhavya Rasayan scheme. But this isn't just about capacity expansion. It's about optionality.

Deloitte's 2027 supply chain outlook identifies "optionality" as the defining competitive advantage: the ability to pivot suppliers, reroute logistics, and maintain production continuity when geopolitical winds shift. Integrated chemical parks deliver exactly that.

Here's why this matters now:

• Co-located production ecosystems reduce dependency on fragmented, multi-country supply chains
• Shared utilities and logistics infrastructure cut lead times from weeks to days
• Regulatory compliance becomes streamlined when manufacturing, testing, and distribution sit within one controlled zone

For nearly four decades, we've watched industrial resilience get tested by tariffs, pandemics, and trade wars. The companies that survived weren't just the largest. They were the most adaptable.

Chemical parks aren't real estate projects. They're insurance policies against the next disruption you can't predict.

The question for CTOs and procurement leaders: Are you building optionality into your supply chain, or are you still betting on stability that no longer exists?

Legacy isn't what you inherit. It's what you build when the future is uncertain.

Your "Made in India" API might be 94% Chinese.India supplies 50% of Africa's medicines, 40% of America's generics, and 2...
02/11/2026

Your "Made in India" API might be 94% Chinese.

India supplies 50% of Africa's medicines, 40% of America's generics, and 25% of the UK's pharmaceutical needs. We are the "pharmacy of the world."

But here's the paradox: 65% of the active pharmaceutical ingredients, key starting materials, and intermediates that power this global supply chain come from a single country — China.

For some critical APIs, that dependency climbs to 94%.

NITI Aayog's June 2026 report exposes a USD 261 billion vulnerability hiding in plain sight. When geopolitical tensions rise or supply routes shift, the world's medicine cabinet is at risk.

This isn't just a pharmaceutical problem. It's a chemical supply chain challenge — and an opportunity.

India's push for API localization, backed by Production Linked Incentive schemes and strategic diversification mandates, is creating demand for reliable domestic chemical distribution networks. Companies that can deliver specialty intermediates, oleochemicals, and pharmaceutical-grade inputs with compliance and consistency will define the next decade of industrial resilience.

At Veeraj Group, we've spent nearly four decades building the infrastructure, relationships, and expertise to support this transition — from specialty resins to pharmaceutical intermediates, from chemical distribution to turnkey industrial facilities.

The question isn't whether India will diversify its pharma supply chain.

It's who will enable it.

Address

Ahmedabad

Alerts

Be the first to know and let us send you an email when Veeraj Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Veeraj Group:

Shortcuts

Share